These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 21363878)
41. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients. Teuffel O; Amir E; Alibhai S; Beyene J; Sung L Br J Cancer; 2011 Apr; 104(9):1377-83. PubMed ID: 21468048 [TBL] [Abstract][Full Text] [Related]
42. Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA. Koenig C; Morgan J; Ammann RA; Sung L; Phillips B Syst Rev; 2019 Apr; 8(1):82. PubMed ID: 30944024 [TBL] [Abstract][Full Text] [Related]
43. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia. Hodgson-Viden H; Grundy PE; Robinson JL BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510 [TBL] [Abstract][Full Text] [Related]
44. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. Chamilos G; Bamias A; Efstathiou E; Zorzou PM; Kastritis E; Kostis E; Papadimitriou C; Dimopoulos MA Cancer; 2005 Jun; 103(12):2629-35. PubMed ID: 15856427 [TBL] [Abstract][Full Text] [Related]
45. Outpatient management of febrile neutropenia: time to revise the present treatment strategy. Carstensen M; Sørensen JB J Support Oncol; 2008; 6(5):199-208. PubMed ID: 18551855 [TBL] [Abstract][Full Text] [Related]
46. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. Taplitz RA; Kennedy EB; Bow EJ; Crews J; Gleason C; Hawley DK; Langston AA; Nastoupil LJ; Rajotte M; Rolston K; Strasfeld L; Flowers CR J Clin Oncol; 2018 May; 36(14):1443-1453. PubMed ID: 29461916 [TBL] [Abstract][Full Text] [Related]
47. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia]. Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179 [TBL] [Abstract][Full Text] [Related]
48. Outpatient management of febrile episodes in neutropenic cancer patients. Rubenstein EB; Rolston K Support Care Cancer; 1994 Nov; 2(6):369-73. PubMed ID: 7858928 [TBL] [Abstract][Full Text] [Related]
49. Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice. Haeusler GM; Slavin MA; Bryant PA; Babl FE; Mechinaud F; Thursky KA J Paediatr Child Health; 2018 Jul; 54(7):761-769. PubMed ID: 29655245 [TBL] [Abstract][Full Text] [Related]
50. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Rubenstein EB; Rolston K; Benjamin RS; Loewy J; Escalante C; Manzullo E; Hughes P; Moreland B; Fender A; Kennedy K Cancer; 1993 Jun; 71(11):3640-6. PubMed ID: 8490912 [TBL] [Abstract][Full Text] [Related]
51. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina. Ammann RA Cancer; 2004 Apr; 100(7):1547; author reply 1547-8. PubMed ID: 15042693 [No Abstract] [Full Text] [Related]
52. Early discharge of pediatric patients with cancer, fever, and neutropenia with low-risk of systemic infection. Gil-Veloz M; Pacheco-Rosas DO; Solórzano-Santos F; Villasís-Keever MA; Betanzos-Cabrera Y; Miranda-Novales G Bol Med Hosp Infant Mex; 2018; 75(6):352-357. PubMed ID: 30407457 [TBL] [Abstract][Full Text] [Related]
53. Implementation of an evidence-based order set to impact initial antibiotic time intervals in adult febrile neutropenia. Best JT; Frith K; Anderson F; Rapp CG; Rioux L; Ciccarello C Oncol Nurs Forum; 2011 Nov; 38(6):661-8. PubMed ID: 22037329 [TBL] [Abstract][Full Text] [Related]
54. The outpatient management of febrile neutropenia in cancer patients. Freifeld AG; Pizzo PA Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296 [TBL] [Abstract][Full Text] [Related]
55. [Current clinical practice in the treatment of febrile neutropenia (FN)]. Takei N; Komatsu T Jpn J Antibiot; 2011 Oct; 64(5):293-310. PubMed ID: 22428213 [TBL] [Abstract][Full Text] [Related]
56. The evolution towards ambulatory and day-case management of febrile neutropenia. Chisholm JC; Dommett R Br J Haematol; 2006 Oct; 135(1):3-16. PubMed ID: 16925575 [TBL] [Abstract][Full Text] [Related]
57. Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer. Escalante CP; Rubenstein EB; Rolston KV Cancer Invest; 1997; 15(3):237-42. PubMed ID: 9171858 [TBL] [Abstract][Full Text] [Related]
58. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study. Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527 [TBL] [Abstract][Full Text] [Related]
59. Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting. Dommett R; Geary J; Freeman S; Hartley J; Sharland M; Davidson A; Tulloh R; Taj M; Stoneham S; Chisholm JC Eur J Cancer; 2009 Nov; 45(16):2843-9. PubMed ID: 19616427 [TBL] [Abstract][Full Text] [Related]
60. Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia. Vedi A; Cohn R J Paediatr Child Health; 2013 Mar; 49(3):170-8. PubMed ID: 22136103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]